Oxford Immunotec Global PLC (OXFD) Q2 2015 Results Earnings Conference Call August 4, 2015 8:00 AM ET
Executives
Mark Klausner - Investor Relations
Peter Wrighton-Smith - Chief Executive Officer
Richard Altieri - Chief Financial Officer
Analysts
Jeffrey Elliot - Robert W. Baird
Tycho Peterson - JPMorgan
Bill Quirk - Piper Jaffray
Doug Schenkel - Cowen and Company
Karen Koski - BTIG
Operator
Good morning, ladies and gentlemen and welcome to the Oxford Immunotec Second Quarter Conference Call. As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mr. Mark Klausner of Westwicke Partners.
Mark Klausner
Good morning and thank you for joining us today for Oxford Immunotec's second quarter 2015 conference call. Joining us on today are Oxford Immunotec's Chief Executive Officer, Dr. Peter Wrighton-Smith and its Chief Financial Officer, Rick Altieri.
Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business.
For a discussion of risks and uncertainties associated with Oxford Immunotec's business, I encourage you to review the company's filings with the Securities and Exchange Commission. The company disclaims any obligation to update any forward-looking statements made during the course of this call.
With that, it's my pleasure to turn the call over to Oxford Immunotec's Chief Executive Officer, Peter Wrighton-Smith.
Peter Wrighton-Smith
Good morning and thank you for joining us today. On today's call, I will provide some general comments on our financial results and operating progress in the second quarter, before handing over to Rick, who will walk you through our
- Read more current OXFD analysis and news
- View all earnings call transcripts